The Great Divorce: Why There Are Two Mercks

Discover how a 17th-century German pharmacy split into two global giants, powering everything from life-saving vaccines to your smartphone screen.[INTRO]ALEX: Jordan, if you walk into a pharmacy in New Jersey, you’ll see the name Merck on bottles of life-saving cancer drugs. But if you walk into a tech lab in Tokyo, you’ll see that same name, Merck, on the liquid crystals inside your smartphone screen.JORDAN: Wait, is that the same company? Or is this like a Dove soap and Dove chocolate situation where they just happen to share a name?ALEX: It’s much weirder. They were the same company until the U.S. government stepped in and forcibly divorced them during World War I, creating a 100-year identity crisis that still confuses the entire planet today.JORDAN: A corporate civil war sparked by a world war? I’m in. Let’s figure out who actually owns the name.[CHAPTER 1 - Origin]ALEX: This story starts incredibly small. We’re going back to 1668 in Darmstadt, Germany. A man named Friedrich Jacob Merck buys the "Angel Pharmacy."JORDAN: 1668? That’s ancient in business years. Most companies don't last through a decade, let alone three and a half centuries.ALEX: Exactly. For 160 years, it stays a local family business. But in 1827, Emanuel Merck changes the game. He stops just selling medicine and starts manufacturing it on an industrial scale, specifically alkaloids like morphine.JORDAN: So he turns a corner drugstore into a chemical factory. That’s a massive leap.ALEX: It worked so well that by 1887, the family sent a son, Georg Merck, to New York to open an American branch. At that moment, they were one big, happy, global family empire.JORDAN: I’m guessing the "happy" part didn't survive the early 20th century.ALEX: Not even close. When World War I broke out, German-owned assets in the U.S. were suddenly considered "enemy property." In 1917, the U.S. government seized the American branch of Merck and sold it off.JORDAN: They just took the company? Who bought it?ALEX: Georg’s son, George W. Merck. He raised the money to buy the shares back from the government, effectively making the American branch a completely independent company from the German parent. The divorce was final, and the two Mercks have been awkward roommates on the global stage ever since.[CHAPTER 2 - Core Story]JORDAN: Okay, so the American Merck and the German Merck are now separate entities. How do they decide who gets to keep the name on the mailbox?ALEX: It’s a legal nightmare. They basically split the world. In the U.S. and Canada, the American company is just "Merck," while the German company has to use the name "EMD."JORDAN: And the rest of the world?ALEX: Total flip. Everywhere else, the German company is "Merck," and the American company has to go by the name "MSD."JORDAN: That sounds like a branding person's literal hell. But besides the name, did their business paths stay the same?ALEX: Not at all. The American Merck became a pharmaceutical titan. They hired a man named Maurice Hilleman, who is honestly the most important scientist you’ve probably never heard of. He developed over 40 vaccines, including the ones for measles, mumps, and chickenpox.JORDAN: Wait, one guy at one company developed almost the entire childhood vaccine schedule?ALEX: Pretty much. His work is credited with saving hundreds of millions of lives. And while the American side was dominating vaccines, the German side, Merck KGaA, took a totally different path. They pivoted into high-tech materials.JORDAN: Like what?ALEX: Liquid crystals. If you are looking at a screen right now—a laptop, a phone, a TV—there is a massive chance the German Merck manufactured the chemicals that make that screen work. They owned about 60% of the world market for liquid crystals at one point.JORDAN: So one Merck is inside my body protecting me from viruses, and the other Merck is in my pocket powering my Instagram feed.ALEX: Essentially. But it hasn't all been scientific breakthroughs and saving the world. The American Merck faced a massive reckoning in 2004 with a drug called Vioxx.JORDAN: I remember that name. That was the painkiller scandal, right?ALEX: It was devastating. Vioxx was a blockbuster, making billions, until it was revealed the drug significantly increased the risk of heart attacks. Merck had to pull it from the market and eventually paid nearly 5 billion dollars to settle thousands of lawsuits.[CHAPTER 3 - Why It Matters]JORDAN: So we have these two giants. One is a tech and chemical hybrid in Germany; the other is a pharma powerhouse in the U.S. Why should we care today?ALEX: Because they represent the two sides of the modern scientific world. On one hand, you have the Mectizan program—where the American Merck has donated over 4 billion doses of medicine to eliminate River Blindness in the developing world for free.JORDAN: That’s a huge humanitarian win.ALEX: It really is. But on the other hand, you have the Vioxx disaster and the current reality of high drug prices. The Merck story shows us that the same company can be a hero and a cautionary tale at the same time.JORDAN: And they’re still growing, right? I saw they have that massive cancer drug, Keytruda.ALEX: Right. Keytruda is currently one of the best-selling drugs on Earth, bringing in over 20 billion dollars a year. But there’s a "patent cliff" coming in 2028 where they lose their exclusive rights, and that’s going to trigger another massive shift in the industry.JORDAN: It’s crazy that a tiny pharmacy from the 1600s is still the engine for both global health and modern electronics.[OUTRO]JORDAN: If I’m at a trivia night and Merck comes up, what’s the one thing I need to remember?ALEX: Remember that Merck is a 350-year-old family legacy that was split in two by a world war, leaving us with one company that powers our screens and another that provides our vaccines.JORDAN: That’s Wikipodia — every story, on demand. Search your next topic at wikipodia.ai